First line chemotherapy plus trastuzumab in metastatic breast cancer HER2 positive - Observational institutional study

Breast cancer is the most common malignant disease and among the most frequent causes of cancer mortality in females worldwide. Metastatic breast cancer (MBC) is conventionally considered to be incurable. In first-line treatment of HER-2 positive MBC, randomized trials have demonstrated that trastuz...

Descripción completa

Detalles Bibliográficos
Autores principales: Aitelhaj, Meryem, Lkhoyaali, Siham, Rais, Ghizlane, Boutayeb, Saber, Errihani, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267845/
https://www.ncbi.nlm.nih.gov/pubmed/28154679
http://dx.doi.org/10.11604/pamj.2016.24.324.4058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267845/
https://www.ncbi.nlm.nih.gov/pubmed/28154679
http://dx.doi.org/10.11604/pamj.2016.24.324.4058

Ejemplares similares